{"organizations": [], "uuid": "4bbd6b2de36099cea8a51d1f140f8298717041d7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-daiichi-sankyo-and-darwinhealth-en/brief-daiichi-sankyo-and-darwinhealth-enter-exclusive-research-collaboration-for-novel-cancer-target-initiative-idUSFWN1RH05G", "country": "US", "domain_rank": 408, "title": "BRIEF-‍Daiichi Sankyo And Darwinhealth Enter Exclusive Research Collaboration For Novel Cancer Target Initiative​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-04T15:11:00.000+03:00", "replies_count": 0, "uuid": "4bbd6b2de36099cea8a51d1f140f8298717041d7"}, "author": "", "url": "https://www.reuters.com/article/brief-daiichi-sankyo-and-darwinhealth-en/brief-daiichi-sankyo-and-darwinhealth-enter-exclusive-research-collaboration-for-novel-cancer-target-initiative-idUSFWN1RH05G", "ord_in_thread": 0, "title": "BRIEF-‍Daiichi Sankyo And Darwinhealth Enter Exclusive Research Collaboration For Novel Cancer Target Initiative​", "locations": [], "entities": {"persons": [{"name": "darwinhealth", "sentiment": "none"}], "locations": [], "organizations": [{"name": "daiichi sankyo", "sentiment": "negative"}, {"name": "daiichi sankyo co ltd", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "daiichi", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 4, 2018 / 12:11 PM / in 26 minutes BRIEF-‍Daiichi Sankyo And Darwinhealth Enter Exclusive Research Collaboration For Novel Cancer Target Initiative​ Reuters Staff \nApril 4 (Reuters) - Daiichi Sankyo Co Ltd: \n* ‍DAIICHI SANKYO AND DARWINHEALTH ENTER EXCLUSIVE RESEARCH COLLABORATION FOR NOVEL CANCER TARGET INITIATIVE​ * ‍DARWINHEALTH WILL RECEIVE AN UPFRONT PAYMENT​ \n* ‍DARWINHEALTH HAS POTENTIAL TO RECEIVE MILESTONE PAYMENTS SHOULD SPECIFIED EVENTS OCCUR RELATING TO DARWINHEALTH’S NOVEL CANCER TARGETS​ \n* CO TO RECEIVE EXCLUSIVE ACCESS TO DARWINHEALTH’S NOVEL CANCER TARGET DATABASE FOR PREDETERMINED AMOUNT OF TIME WITH OPTION TO EXTEND​ \n* ‍FINANCIAL TERMS OF AGREEMENT WERE NOT DISCLOSED​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)", "external_links": [], "published": "2018-04-04T15:11:00.000+03:00", "crawled": "2018-04-04T15:39:50.039+03:00", "highlightTitle": ""}